Treatment success rate for patients treated for MDR-TB in Hong Kong, China
Hong Kong, China: Treatment success rate for patients treated for MDR-TB was 72.0% in 2022. ▲ Rising
Latest (2022)
72.0%
Change on year
down 22.6%
World rank
87th
of 163 countries
All-time high
93.0%
in 2021
All-time low
53.0%
in 2004
Years of data
20
2002–2022
Treatment success rate for patients treated for MDR-TB in Hong Kong, China, 2002–2022
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for treatment success rate for patients treated for mdr-tb in Hong Kong, China is 72.0%, measured in 2022.
That represents a change of down 22.6% on the previous year and up 14.3% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Hong Kong, China peaked at 93.0% in 2021 and was at its lowest, 53.0%, in 2004.
Hong Kong, China ranks 87th of 163 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 20 years of available data.
Treatment success rate for patients treated for MDR-TB in Hong Kong, China, year by year
| Year | Value | Change |
|---|---|---|
| 2002 | 86.0% | — |
| 2003 | 71.0% | -17.4% |
| 2004 | 53.0% | -25.4% |
| 2006 | 56.0% | +5.7% |
| 2007 | 62.0% | +10.7% |
| 2008 | 62.0% | +0.0% |
| 2009 | 53.0% | -14.5% |
| 2010 | 67.0% | +26.4% |
| 2011 | 60.0% | -10.4% |
| 2012 | 63.0% | +5.0% |
| 2013 | 63.0% | +0.0% |
| 2014 | 85.0% | +34.9% |
| 2015 | 71.0% | -16.5% |
| 2016 | 75.0% | +5.6% |
| 2017 | 85.0% | +13.3% |
| 2018 | 60.0% | -29.4% |
| 2019 | 79.0% | +31.7% |
| 2020 | 75.0% | -5.1% |
| 2021 | 93.0% | +24.0% |
| 2022 | 72.0% | -22.6% |
Hong Kong, China compared with similar countries
- Hong Kong, China's 72.0% is above the median for high income countries, which is 66.0%, 1.1× the median. (48 countries reporting)
- Hong Kong, China's 72.0% is below the median for East Asia & Pacific, which is 73.0%, 99% of the median. (24 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 63.3% | 53.0% | 86.0% | 7 |
| 2010s | 70.8% | 60.0% | 85.0% | 10 |
| 2020s | 80.0% | 72.0% | 93.0% | 3 |
Countries ranked near Hong Kong, China
- 87 Afghanistan 72.0% compare
- 87 Iran, Islamic Republic of 72.0% compare
- 87 Niger 72.0% compare
More health data for Hong Kong, China
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0171 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,924 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.73 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0137 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Hong Kong, China?
- Treatment success rate for patients treated for mdr-tb in Hong Kong, China was 72.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Hong Kong, China?
- The highest recorded value was 93.0% in 2021.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Hong Kong, China?
- The lowest recorded value was 53.0% in 2004.
- How does Hong Kong, China rank for treatment success rate for patients treated for mdr-tb?
- Hong Kong, China ranks 87th out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Hong Kong, China?
- Over the last ten years it is up 14.3%. The long-run trend across the full record is rising.
- Where does this Hong Kong, China data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).